Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
An article in Everyday Health referenced a study published in a 2016 supplement to The American Journal of Managed Care® (AJMC®). The study, “Overview of Diabetic Macular Edema,” described the spending estimates and substantial burden of diabetic retinopathy and diabetic macular edema on patients, caregivers, and health care systems.
A piece by Lake County News referenced an article published on AJMC.com, the website of AJMC. The article, “Vision Impairment Found in More Than a Quarter of Older US Adults,” described how the prevalence of vision impairment in adults older than 71 years had increased in 2021 compared with previous estimates.
What Mass General Brigham is Doing to Combat Prostate Cancer Disparities Among Men of Color
May 5th 2024Quoc-Dien Trinh, MD, MBA, chief of urology at Brigham & Women's Faulkner Hospital, highlighted successful efforts to improve prostate cancer care access for underserved communities in Massachusetts.
Read More
Tackling Health Inequality: The Power of Education and Experience
April 30th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our final episode of this limited series and our conversation with Janine Jelks-Seale, MSPPM, director of health equity at UPMC Health Plan.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
AUA Posters Highlight Racial Gaps in PSA Screening, Prostate Cancer Risk
May 4th 2024Speakers discussed the disparities in prostate-specific antigen (PSA) screening rates among different racial groups and explored the potential of free PSA percentage as a predictive marker for future prostate cancer risk.
Read More